AADAC anticorps (N-Term)

N° du produit ABIN2782106

Détail du produit anti-AADAC anticorps

Antigène: AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))

Épitope: N-Term

Reactivité: Humain, Souris, Rat, Cheval, Lapin, Chien, Cobaye

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp AADAC est non-conjugé

Application: Western Blotting (WB)

Séquence: AHLKTIQNLA TFVELLGLHH FMDSFKVVGS FDEVPPTSDE NVTVTETKFN

Homologie: Dog: 100%, Guinea Pig: 92%, Horse: 100%, Human: 100%, Mouse: 91%, Rabbit: 100%, Rat: 90%

Attributs du produit: This is a rabbit polyclonal antibody against AADAC. It was validated on Western Blot using a cell lysate as a positive control.

Purification: Affinity Purified

Immunogène: The immunogen is a synthetic peptide directed towards the N terminal region of human AADAC

Information d'application

Indications d'application: Optimal working dilutions should be determined experimentally by the investigator.

Commentaires:

Antigen size: 399 AA

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze-thaw cycles.

Stock: -20 °C

Stockage commentaire: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Détails sur AADAC

Antigène: AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))

Autre désignation: AADAC (AADAC Produits)

Sujet: Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-5 AV705031.1 1-5 6-247 L32179.1 1-242 248-1725 BC032309.1 183-1660
Alias Symbols: CES5A1, DAC
Protein Size: 399

Poids moléculaire: 46 kDa

ID gène: 13

NCBI Accession: NM_001086, NP_001077

UniProt: P22760